Table 3.
Exploratory outcomes at baseline, 6 months, and 2.5 years, N=26
| Baseline | 6 Months | 2.5 years | ||
|---|---|---|---|---|
| Metabolic Syndrome Components, n(%) |
Abdominal Obesity: ≥102 cm (men); ≥ 88cm (women) |
25 (96.2) | 20 (76.9) | 23 (88.5) |
| Blood Pressure: ≥130/85 mmHg or on antihypertensive drugs |
23 (88.5) | 19 (73.1) | 21 (80.8) | |
| HDL Cholesterol <1.0 mmol/L (men); <1.3 mmol/L (women) |
14 (53.8) | 7 (26.9) | 8 (30.8) | |
| Triglycerides: ≥1.70 mmol/L |
10 (38.5) | 4 (15.4) | 4 (15.4) | |
| Glucose: ≥5.56 mmol/L |
15 (57.7) | 13 (50.0) | 7 (26.9) | |
| Metabolic Syndrome Severity, mean(sd) |
0.8 (0.6) | 0.4 (0.7) | 0.2 (0.9) | |
| Weight | Weight Loss ≥ 5%, n(%) | N/A | 12 (46.2) | 10 (38.5) |
| Weight Loss, kg, mean(sd) |
N/A | −5.7 (6.5) | −3.0 (7.6) | |
| Body Mass Index, mean(sd) |
35.2 (7.3) | 33.1 (7.4) | 34.1 (7.0) | |
| Medication Use | Anti-hypertensivesa, n(%) | 20 (100.0) | 14 (70.0) | 15 (75.0) |
| Lifestyle | Vegetable Servings/day, mean(sd) |
3.1 (2.7) | 3.9 (3.3) | 4.6 (3.6) |
| Sugar Sweetened Beverages/dayc, mean(sd) |
1.4 (2.2) | 0.9 (2.1) | 1.3 (2.3) | |
| Moderate-to-Vigorous Physical Activity min/wkd, mean(sd) |
112.5 (152.1) | 165.3 (164.1) | 152.9 (206.5) | |
| Daily Stepsd, mean(sd) | 6253.9 (2330.8) | 7542.9 (2922.8) | 7149.3 (3149.8) | |
| Energy and Vitalityb, mean(sd) |
60.6 (15.8) | 68.8 (21.4) | 72.3(17.4) | |
| Psychosocial | Social Supporte, mean(sd) |
71.3 (26.8) | 77.8 (21.0) | 82.8 (23.2) |
| Depressive Symptomsf, mean(sd) |
4.5 (4.4) | 2.4 (2.3) | 2.9 (3.0) | |
| Negative Affectg, mean(sd) | 15.0 (7.4) | 13.6 (5.6) | 13.4 (5.7) |
a
In the 20 participants who had treated hypertension at baseline
b
Medical Outcomes Study (MOS) Short Form Health Survey
c
The National Cancer Institute Fruit and Vegetable Screener
d
Accelerometer
e
Medical Outcomes Study Social Support Scale
f
The Patient Health Questionnaire (PHQ-8)
g
The Positive and Negative Affect Schedule (PANAS)